Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

Bibliographic Details
Title: Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Authors: Rescigno, Pasquale, Dolling, David, Conteduca, Vincenza, Rediti, Mattia, Bianchini, Diletta, Lolli, Cristian, Ong, Michael, Li, Haoran, Omlin, Aurelius G., Schmid, Sabine, Caffo, Orazio, Zivi, Andrea, Pezaro, Carmel J., Morley, Courtney, Olmos, David, Romero-Laorden, Nuria, Castro, Elena, Saez, Maria I., Mehra, Niven, Smeenk, Stella, Sideris, Spyridon, Gil, Thyerry, Banks, Patricia, Sandhu, Shaneen K., Sternberg, Cora N., De Giorgi, Ugo, De Bono, Johann S.
Source: In European Urology Oncology April 2020 3(2):176-182
Database: ScienceDirect
More Details
ISSN:25889311
DOI:10.1016/j.euo.2019.06.008
Published in:European Urology Oncology
Language:English